ACRV

Acrivon Therapeutics, Inc.

Acrivon Therapeutics, Inc. (ACRV) has 21 SEC Form 4 filings (23 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 23, 2026.

  • Industry:Biotechnology
  • CEO:Peter Blume-Jensen
  • Employees:75
  • HQ:Watertown, MA, US
  • IPO:2022-11-15

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1K

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$71.5M

latest known value

Source
Miller MaryFirst filing
Sale$1KJul 23SEC ↗

Related companies

Acrivon Therapeutics, Inc. is in the Healthcare sector.